INFANTS' TYLENOL ORAL SUSPENSION OTC
Generic Name and Formulations:
Acetaminophen 160mg/5mL; cherry or grape flavor; alcohol-free.
McNeil Consumer Healthcare
Indications for INFANTS' TYLENOL ORAL SUSPENSION:
Minor aches and pain. Fever.
Dispense liquid slowly in mouth toward inner cheek. <24lbs or <2yrs: consult doctor. 24–35lbs or 2–3yrs: 5mL (160mg) every 4hrs; max 5 doses/24hrs.
Hepatic dysfunction. Reevaluate if severe sore throat persists >2 days with or followed by fever, headache, rash, nausea or vomiting. Discontinue if new symptoms occur, pain worsens >5 days, fever persists >3 days, or if redness or swelling is present.
Do not use with other acetaminophen-containing drugs. Caution with concomitant warfarin.
Susp (w. oral syringe)—1oz (grape); 2oz (cherry)
Sign Up for Free e-newsletters
- Managing Chemo Brain in Pediatric Survivors of Childhood Cancer
- Aggressive Therapy Provides No Additional Advantage in Metastatic Prostate Cancer
- Excretion of Volatile Organic Compounds Higher in AYAs Using Vaping Products
- FDA, ASHP Actions to Prevent or Manage Chemotherapy Drug Shortages
- Breast Cancer Screening Recommendations Not Completely Reflective of Race, Age
- Various Aspects of Palliative Care Focus Associated With Different Outcomes In Cancer
- Cost vs Benefits: The Controversy Over Proton Beam Radiotherapy
- Patient Expectations at Odds With Actual Outcomes for Radiotherapy in Breast Cancer
- Patients Desire More Online Tools and Access
- Metformin Plus Ruxolitinib: A Potential Therapeutic Alternative for Myeloproliferative Neoplasms
- Sexual Quality of Life Decreased During, After Chemotherapy for Digestive Cancers
- CHEMO-SUPPORT: A Nursing Intervention to Relieve Chemotherapy Symptom Burden
- Approach and Management of Checkpoint Inhibitor-related Immune Hepatitis
- Revised AJCC8 Demonstrates Superior Tumor Classification for HNCSCC
- Oral Androgen Receptor Inhibitor Granted FDA Approval for Nonmetastatic CRPC
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|